P.J. Wyld

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

The French Cooperative Group on CLL, S.A. Johnson, Alex Smith et al. · The Lancet · 1996 · 438 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +7

Serum <i>HER-2/neu</i> and Response to the Aromatase Inhibitor Letrozole Versus Tamoxifen

A. Lipton, Suhail M. Ali, Kim Leitzel et al. · Journal of Clinical Oncology · 2003 · 125 citations

Arimidex (ZD1033): a selective, potent inhibitor of aromatase in postmenopausal female volunteers

R. A. Yates, Mitch Dowsett, G V Fisher et al. · British Journal of Cancer · 1996 · 95 citations · Full text

Hormonal Contraceptive, Postmenopausal Female Volunteers, Potent Inhibitor +11

Pharmacokinetics of valsartan in patients with liver disease

L Brookman, Paul Rolan, I S Benjamin et al. · Clinical Pharmacology & Therapeutics · 1997 · 93 citations

Does multisomy of chromosome 1q confer a proliferative advantage in B-cell acute lymphoblastic leukemia

Christine M. Morris, P. H. Fitzgerald, Mark A. Neville et al. · Cancer · 1984 · 46 citations · Full text